Related Experiment Video
Updated: Jun 9, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
The Association Between Fibrosis-4 Index and All-Cause and Cardiac Mortality in Patients With Coronary Heart Disease
Chenxi Song1,2, Zhihao Zheng1,2, Xiaohui Bian1,2
1Department of Cardiology Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Insights
The fibrosis-4 index (FIB-4) score, a noninvasive liver fibrosis marker, is linked to increased all-cause and cardiac mortality risks in patients with diabetes/prediabetes and cardiovascular disease.
Area of Science:
- Cardiology
- Hepatology
- Metabolic Diseases
Background:
- Cardiovascular disease (CVD) and diabetes/prediabetes are significant risk factors for mortality.
- Liver fibrosis, identified by the fibrosis-4 index (FIB-4), is increasingly recognized as a potential contributor to systemic health risks.
- The association between FIB-4 and mortality in patients with both CVD and diabetes/prediabetes is not well-established.
Purpose of the Study:
- To investigate the impact of the fibrosis-4 index (FIB-4) on all-cause and cardiac mortality.
- To evaluate FIB-4's prognostic value in a high-risk population with diabetes or prediabetes and confirmed cardiovascular disease.
Main Methods:
- Analysis of two large patient cohorts: Fuwai Hospital (N=20,133) and UK Biobank (N=5678).
- Utilized multivariable Cox regression analysis to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).
- Adjusted for multiple confounding factors including glucose levels, age, sex, and body mass index.
Main Results:
- Elevated FIB-4 scores were significantly associated with increased hazards of all-cause mortality in both cohorts (Fuwai: HR 2.58; UKB: HR 1.26).
- Elevated FIB-4 scores were also significantly associated with increased hazards of cardiac mortality in both cohorts (Fuwai: HR 2.99; UKB: HR 1.41).
- These associations remained consistent across various subgroups, including different glucose levels, age, sex, and BMI.
Conclusions:
- Liver fibrosis, as indicated by FIB-4, is a significant predictor of elevated all-cause and cardiac mortality.
- FIB-4 assessment should be considered for risk stratification in patients with coronary heart disease and co-existing diabetes or prediabetes.
Abstract:
Determining the link between fibrosis-4 index (FIB-4) score, which serves as a noninvasive metric for identifying liver cirrhosis, and mortality risks from all causes and cardiac causes in individuals with diabetes or prediabetes and confirmed cardiovascular disease remains ambiguous. This study seeks to explore the impact of FIB-4 on all-cause and cardiac mortality within this high-risk clinical group. Two large-scale patient cohorts were utilized for evaluation: patients from Fuwai Hospital (N = 20,133) and the UK Biobank (N = 5678). Multivariable Cox regression analysis was employed to estimate hazard ratios (HRs) along with the associated 95% confidence intervals (CIs). In the fully adjusted models, the elevated FIB-4 category showed a significant association with elevated hazards of all-cause death (Fuwai Cohort: HR 2.58, 95% CI 1.95-3.42; UKB Cohort: HR 1.26, 95% CI 1.06-1.50) and cardiac mortality (Fuwai Cohort: HR 2.99, 95% CI 1.92-4.66; UKB Cohort: HR 1.41, 95% CI 1.08-1.84). Consistent findings were observed in subgroups based on glucose levels, age, sex, and body mass index. Liver fibrosis, assessed via FIB-4, showed a significant association with elevated mortality hazards and ought to be incorporated into risk stratification among individuals with coronary heart disease concomitant with either diabetes or prediabetic states.
Related Concept Videos
Coronary Artery Disease I: Introduction
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation